Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseMarc S. Sabatine, Terje R. Pedersen, Sabina A. Murphy et al.|New England Journal of Medicine|2017Cited by 6k
Edoxaban versus Warfarin in Patients with Atrial FibrillationRobert P. Giugliano, Elliott M. Antman|New England Journal of Medicine|2013Cited by 5.1k
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at PresentationDavid A. Morrow, Eugene Braunwald, Elliott M. Antman et al.|Circulation|2000Cited by 1.6k
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular EventsMarc S. Sabatine, Evan A. Stein, Robert P. Giugliano et al.|New England Journal of Medicine|2015Cited by 1.5k
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery DiseaseMarc P. Bonaca, Marc S. Sabatine, Patrice Nault et al.|Circulation|2017Cited by 754